Albert David

What Albert David does

Albert David Limited is a publicly listed Indian pharmaceutical manufacturer founded in 1938 and headquartered in Kolkata, India, operating as part of the Kothari Group. The company manufactures a broad portfolio of pharmaceutical formulations across parenterals (amino acid infusions, anti-leishmaniasis injectables, large and small volume parenterals, neurotropic vitamins, placental extract), oral/enteral dosage forms (anti-microbials, anti-ulcerants, NSAIDs, haematinics, hepatoprotectives, vitamins, respiratory, expectorants, probiotics, uterotonics), topical agents, ophthalmic / vision care products, herbal / ayurvedic formulations, bulk drug APIs, and disposable syringes. Its two flagship proprietary products — Sodium Stibogluconate for leishmaniasis (Kalazar) treatment and Placentrex human placenta extract therapy — are protected as trade secrets and, in the case of Placentrex, are described as the only indigenous human placenta-based product in India with over 60 years of clinical use history.

The company's manufacturing footprint centers on two WHO GMP-certified facilities in Kolkata (which also holds USFDA cGMP-compliant Small Volume Parenterals suite) and Ghaziabad (ISO 9001:2008 certified, with aseptic, soft gelatin capsule, ophthalmic, and IV fluid capabilities). A third unit at Mandideep was closed and divested in 2018-2019. Bulk drug APIs are manufactured under USFDA Drug Master File approval and EDQM certification. Revenue is generated through B2B sales to hospitals, pharmacies, and medical practitioners via a 2,200+ stockist domestic distribution network with company-operated sales depots in Kolkata, Lucknow, Patna, and Mumbai, and through international exports to approximately 35 countries via the IDA Amsterdam channel partnership for anti-leishmaniasis APIs. Disclosed revenue for FY 2022-23 was Rs. 342 Crores (~USD 42 Mn), placing Albert David among the top 100 pharmaceutical companies in India out of 22,000+ competitors.

Name

Albert David

Legal name

Albert David Limited

Website

https://albertdavidindia.com

Company type

Public

Founded year

1938

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Albert David Limited is a Kolkata-based, publicly listed Indian pharmaceutical manufacturer (founded 1938, Kothari Group) producing formulations, parenterals, infusion solutions, herbal dosages, bulk APIs, and disposables for hospitals, pharmacies, and distributors across India and 35 export markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Ophthalmic & Otic Generics (HLAIABAF), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Pharmaceutical formulations
• Parenteral injections
• Infusion solutions
• Bulk drug APIs
• Herbal dosage forms

Headquarters

HQ city

Kolkata

HQ country

India

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Formulations Sales: Manufacture and sale of pharmaceutical formulations including parenterals, oral/enteral medications, topical agents, and vision care products to domestic and international markets
2. Bulk Drugs Manufacturing: Manufacturing and sale of bulk drug APIs, including Sodium Stibogluconate for leishmaniasis treatment exported worldwide
3. Herbal Dosage Forms: Production and sale of herbal pharmaceutical products including Placentrex and other ayurvedic formulations
4. International Exports: Export of pharmaceutical products to South East Asia, Africa, Middle East, Europe, USA, and Latin America covering approximately 35 countries

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Albert David Limited manufactures and sells pharmaceutical formulations including parenterals, oral and enteral medications, topical agents, vision care products, herbal/ayurvedic dosage forms, bulk drug active pharmaceutical ingredients (APIs), and disposable syringes and needles. The company's products are sold to hospitals, pharmacies, and medical practitioners through a domestic stockist network of 2200+ distributors and exported to approximately 35 countries worldwide.

Product overview

Albert David Limited is a pharmaceutical manufacturing company producing a comprehensive portfolio of drug formulations. The company operates a platform-based manufacturing model with multiple product lines spanning: Parenterals (including amino acid infusions like Alamin SE/SN, IV solutions, and small volume injectables), Oral/Enteral formulations (tablets, capsules, syrups across therapeutic areas including anti-microbials, anti-ulcerants, NSAIDs, haematinics, hepatoprotectives, and nutritional supplements), Topical Agents (gels, creams including Placentrex line), Vision Care (eye drops for glaucoma, anti-infectives, and tear substitutes), and Bulk Drugs (APIs including anti-leishmaniasis treatments). The company's flagship products include Placentrex (human placenta extract therapy, the only such indigenous product in India with 60+ years of history) and Sodium Stibogluconate (anti-leishmanial injection distributed globally). Manufacturing facilities are WHO GMP certified across Kolkata, Ghaziabad, and Mandideep locations.

Differentiator

Problem solved

Functional benefit

Products and services

• Sodium Stibogluconate Injection (Sodium Antimony Gluconate) Anti-parasitic, anti-leishmanial injection manufactured by Albert David under the name Sodium Antimony Gluconate and distributed worldwide through IDA Amsterdam for the treatment of leishmaniasis (Kalazar).
• Placentrex Injection Human placenta extract injection derived from 0.1gm of fresh human placenta per ml, used for treatment of Pelvic Inflammatory Disease (PID) in combination with antimicrobials. The only human placenta-based product in India developed through indigenous research with over 60 years of clinical history.
• Placentrex Cream and Gel (Placenta Extract Topical) Topical wound healer formulations derived from human placenta extract, containing glutamic acid, leucine, and lysine, indicated for tissue regeneration and anti-inflammatory use.
• Alamin SE Injection (Amino Acid Infusion) Special amino acid infusion in 200ml glass bottles indicated for cancer cachexia, malnourished states requiring lower protein concentration, and renal failure patients undergoing haemodialysis; introduced in collaboration with Morishita Pharmaceuticals Ltd., Japan.
• Alamin SN Injection (Amino Acid Infusion) Special amino acid infusion in 100ml packaging indicated for hypermetabolic states requiring protein supplementation and pregnancy complications due to nutritional deficiency; introduced in collaboration with Morishita Pharmaceuticals Ltd., Japan.
• Large Volume Parenterals (LVP) - IV Solutions Intravenous solutions including Dextrose 5%/10%, Ringer Lactate, Mannitol 20%, and Sodium Chloride solutions in various pack sizes (500ml-1000ml) for fluid and electrolyte replacement; first introduced in India in 1985 in polyethylene containers using Rommelag bottle pack machine model BP 302.
• Small Volume Parenterals (SVP) Injectable formulations in small volumes including antibiotics (Ciprofloxacin, Metronidazole), neurotropic vitamins (SIONEURON FORTE), haemostatics (ALSTAT), and tocolytics (Adilan), produced at USFDA cGMP compliant facilities.
• Siokof-AS Syrup (Expectorant/Cough Syrup) Expectorant and cough syrup containing Ambroxol 15mg, Terbutaline 1.25mg, and Guaifenesin 50mg per 5ml, for the relief of cough and respiratory symptoms.
• Eye Drops (Vision Care) Ophthalmic products including anti-glaucoma drops (ZOLOTIM, SIOTIM), anti-infective drops (CIPAD, SIOGAT, SIOFLOX, SIOMOX), NSAID drops (SIOFLUR), and tear substitutes (SIOTEARS, TEAREX).
• Herbal and Ayurvedic Dosage Forms Herbal and ayurvedic pharmaceutical products including hepatoprotective Adliv, uterotonic Siocare, and rejuvenator Siotone, leveraging traditional herbal ingredients in modern dosage forms.
• Bulk Drug APIs Active Pharmaceutical Ingredients (APIs) manufactured at USFDA-approved facilities, including APIs for anti-leishmaniasis drugs distributed globally; holds US FDA Drug Master File (DMF) approvals and EDQM certification.
• Disposable Syringes and Needles Medical disposables including syringes and needles for drug administration, complementing the company's parenteral pharmaceutical portfolio.

Quantifiable outcome

• Rs. 342 Crores annual sales turnover (FY 2022-23)
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Morishita Pharmaceuticals Ltd. (Japan)coreStrategic or Co-development Partner · 1 January 1987Collaboration established in 1987 with Morishita Pharmaceuticals Ltd., a sister concern of Ajino Moto Co., Inc., Japan for introduction of special amino acid intravenous infusion solutions (Alamin SN-200ml and Alamin SE-200ml) in India.
• Indian Institute of Chemical Biology (CSIR)minorStrategic or Co-development PartnerStrategic liaison with academic institute for outsourcing of research and development activities
• Department of Biotechnology, Calcutta UniversityminorStrategic or Co-development PartnerStrategic liaison with academic institute for outsourcing of research and development activities
• IDA AmsterdamcoreChannel Partner/ Reseller/ DistributorInternational distributor partnership for worldwide distribution of Sodium Stibogluconate (used to treat leishmaniasis/Kalazar), manufactured by Albert David Ltd under the name Sodium Antimony Gluconate

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/albert-david-limited---india

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Albert David